6. Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, 17.
Migliorini P. Autoantibodies specific for alpha-enolase in systemic
autoimmune disorders. J Rheumatol 2000;27:109–15. 18.
7. Roozendaal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH,
Limburg PC, et al. Catalase and alpha-enolase: two novel granulocyte 19.
autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol
1998;112:10 – 6. 20.
8. Jankovic BD, Djordjijevic D. Differential appearance of autoantibodies
to human brain S100 protein, neuron specific enolase and myelin basic
protein in psychiatric patients. Int J Neurosci 1991;60:119 – 27. 21.
9. Fernandez Madrid F. Autoantibodies in breast cancer sera: candidate
biomarkers and reporters of tumorigenesis. Cancer Lett 2005;230:187–98. 22.
10. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R,
et al. Human neoplasms elicit multiple specific immune responses in
23.
the autologous host. Proc Natl Acad Sci USA 1995;92:11810 – 3.
11. tan EM. Autoantibodies as reporters identifying aberrant cellular
mechanisms in tumorigenesis. J Clin Invest 2001;108:1411 – 5.
12. tureci O, Mack U, Luxemburger U, Heinen H, Krummenauer F,
24.
Sester M, et al. Humoral immune responses of lung cancer patients
against tumor antigen NY-ESO-1. Cancer Lett 2006;236:64–71.
13. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H,
25.
Olshen AB, et al. Differential exoprotease activities confer tumor-specific
serum peptidome patterns. J Clin Invest 2006;116:271–84.
14. Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as
biomarkers for early cancer detection. FEBS J 2009;276:6880 – 904.
26.
15. Gitlits VM, Toh BH, Sentry JW. Disease association, origin, and
clinical relevance of autoantibodies to the glycolytic enzyme enolase.
J Investig Med 2001;49:138 – 45.
16. Li WH, Zhao J, Li HY, Liu H, Li AL, Wang HX, et al. 27.
Proteomics-based identification of autoantibodies in the sera of healthy
Chinese individuals from Beijing. Proteomics 2006;6:4781 – 9.
